首页> 美国卫生研究院文献>BMC Pulmonary Medicine >The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers patient-related healthcare system markers and the trajectory of COPD patients treated in primary care
【2h】

The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers patient-related healthcare system markers and the trajectory of COPD patients treated in primary care

机译:PROTECCT-M研究:一项队列研究研究了新型特定生物标志物患者相关的医疗保健系统标志物与在初级保健中治疗的COPD患者的轨迹之间的关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundChronic Obstructive Pulmonary Disease (COPD) is the most common severe chronic disease in primary care. It is typically diagnosed at a late stage, and it is also difficult to predict its trajectory and hence to tailor treatment and rehabilitation. The overall aim is to study determinants of exacerbations of COPD treated in primary care and to study, if the prognosis is related to patient-related, healthcare system markers or levels of the potential biomarkers such as microfibrillar-associated protein 4 (MFAP4) and surfactant protein D (SP-D). Furthermore, we aim to establish a cohort of COPD patients treated in Danish primary care comprising register data, data captured from the GPs’ electronic patient record system (EPR) and a biobank in order to make analyses on factors associated with different tractories of COPD treated in primary care.
机译:背景慢性阻塞性肺疾病(COPD)是基层医疗中最常见的严重慢性疾病。它通常在晚期被诊断出来,并且也很难预测其轨迹,因此难以调整治疗和康复。总体目标是研究在初级保健中治疗的COPD恶化的决定因素,并研究预后是否与患者相关的医疗保健系统标志物或潜在的生物标志物水平(例如微纤维相关蛋白4(MFAP4)和表面活性剂)相关蛋白质D(SP-D)。此外,我们的目标是建立一个由丹麦基层医疗机构治疗的COPD患者队列,其中包括注册数据,从全科医生的电子患者病历系统(EPR)和生物库中捕获的数据,以便分析与治疗COPD的不同拖拉机相关的因素在初级保健中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号